SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-077611
Filing Date
2024-03-26
Accepted
2024-03-26 16:12:02
Documents
15
Period of Report
2024-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d819834d8k.htm   iXBRL 8-K 27325
2 EX-10.1 d819834dex101.htm EX-10.1 15763
6 GRAPHIC g819834dsp4.jpg GRAPHIC 21646
  Complete submission text file 0001193125-24-077611.txt   198837

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20240325.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20240325_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20240325_pre.xml EX-101.PRE 10823
19 EXTRACTED XBRL INSTANCE DOCUMENT d819834d8k_htm.xml XML 3521
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 24783653
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)